Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01371266 · ClinicalTrials.gov registry record · NA
Glycemic Effects of Honey
A NA study, sponsored by USDA Grand Forks Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT01371266 is a NA study that has completed, run by USDA Grand Forks Human Nutrition Research Center. The registered enrollment target is 55 participants.
The verdict
NCT01371266, a NA study, has completed, sponsored by USDA Grand Forks Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
Honey has been used as a sweetener for centuries. Recent data indicate that honey consumption may have beneficial effects upon glucose intolerance, a health issue currently affecting 57 million Americans of every age and ethnicity. In order to evaluate the glycemic effect of honey, the investigators will carry out a human trial assessing biomarkers of blood glucose responses, insulin sensitivity, oxidative stress, and inflammatory markers. Our primary objective is to determine the glycemic effects of honey in comparison to sucrose and high fructose corn syrup (HFCS). The investigators hypothesize that honey will promote improved glucose tolerance and insulin sensitivity compared to both sucrose and high fructose corn syrup in normal glycemic and glucose intolerant adults.
Interventions
- DIETARY_SUPPLEMENT Honey
- DIETARY_SUPPLEMENT High Fructose Corn Syrup 55 (HFCS 55)
- DIETARY_SUPPLEMENT CHO (sugar)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2011-06 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01371266
The ClinicalTrials.gov registry entry for NCT01371266 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is USDA Grand Forks Human Nutrition Research Center, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Honey is the first listed.
NCT01371266 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01371266 about?
NCT01371266 is a clinical study titled "Glycemic Effects of Honey". Honey has been used as a sweetener for centuries. Recent data indicate that honey consumption may have beneficial effects upon glucose intolerance, a health issue currently affecting 57 million Americans of every age and ethnicity. In order to evaluate the glycemic effect of honey, the investigators...
What is the current status of trial NCT01371266?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2011-06. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01371266?
The interventions under investigation include: Honey (DIETARY_SUPPLEMENT), High Fructose Corn Syrup 55 (HFCS 55) (DIETARY_SUPPLEMENT), CHO (sugar) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01371266?
This trial is sponsored by USDA Grand Forks Human Nutrition Research Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.